March 7, 2024 · Form 4 insider transaction
Lippis Daniel J. sold 1,715 shares of Edwards Lifesciences Corporation at $90.98 per share, a transaction worth $156.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.